SARS-CoV-2 triggers the production of the antiviral protein IFN-γ, which is associated with fatigue, muscle ache and depression. New research shows that in Long COVID patients, IFN-y production persists until symptoms improve, highlighting a potential biomarker and a target for therapies.
Scientists still are not sure how neurological symptoms arise in COVID-19.
The efficiency of oxygen supply to tissues is a factor in the severity of important diseases such as Covid-19 and heart conditions.
Delays in diagnosing melanoma due to Covid-19 lockdowns may have contributed to over 100,000 years of life lost across Europe and over £6bn in costs, mainly indirectly due to loss of productivity, finds a new study led by UCL and University Hospital of Basel researchers.
Testing wastewater to assess the spread of the COVID-19 virus became common and well-publicized during the pandemic, but it has been focused mostly on urban areas.
The governing board of the New Jersey Integrated Population Health Data (iPHD) Project in December approved the release of data – along with pilot funding and data access fee waivers – for six research proposals to study the top challenges of the state’s population health.
In a study involving nearly 1,000 patients seen at the Baltimore Convention Center Field Hospital (BCCFH) during a five-month period in 2022 — researchers at Johns Hopkins Medicine, the University of Maryland School of Medicine and five other collaborators report that a rapid antigen test (RAT) for detecting SARS-CoV-2, the virus that causes COVID-19, can be used at home with accuracy comparable to the same test being administered by a health care professional.
SMU nanotechnology expert MinJun Kim helped a team of researchers at The University of Texas at Austin to develop a less expensive way to detect nuclease digestion – one of the critical steps in many nucleic acid sensing applications, such as those used to identify COVID-19.
Children’s Hospital Los Angeles is one of 10 pediatric sites involved in the nationwide Researching COVID to Enhance Recovery (RECOVER) Initiative, sponsored by the National Institutes of Health to improve the diagnosis, treatment and prevention of long COVID in children.
Therapies for pain conditions like fibromyalgia provide clues for helping those with long COVID, finds a new University of Michigan study.
RSS
Medicine keyboard_arrow_right
Sciencekeyboard_arrow_right
Life keyboard_arrow_right
Business keyboard_arrow_right
Journal News keyboard_arrow_right
By Location keyboard_arrow_right
Meetings, Grants, and Events keyboard_arrow_right
